Lee Edward T 4
4 · RH · Filed Nov 17, 2022
Insider Transaction Report
Form 4
RHRH
Lee Edward T
SEE REMARKS
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-11-15−1,250→ 3,000 totalExercise: $101.25Exp: 2029-04-01→ Common Stock (1,250 underlying) - Sale
Common Stock
2022-11-15$300.00/sh−540$162,000→ 2,624 total - Exercise/Conversion
Common Stock
2022-11-15$154.82/sh+400$61,928→ 3,024 total - Sale
Common Stock
2022-11-15$300.00/sh−400$120,000→ 2,624 total - Exercise/Conversion
Common Stock
2022-11-15$87.31/sh+540$47,147→ 3,164 total - Exercise/Conversion
Common Stock
2022-11-15$101.25/sh+1,250$126,563→ 3,874 total - Sale
Common Stock
2022-11-15$300.00/sh−1,250$375,000→ 2,624 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-11-15−400→ 3,200 totalExercise: $154.82Exp: 2030-04-28→ Common Stock (400 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2022-11-15−540→ 0 totalExercise: $87.31Exp: 2025-05-05→ Common Stock (540 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Option vested in five equal annual installments beginning on 5/6/2016 and ending on 5/6/2020.
- [F3]This option award is vested and exercisable with respect to 1250 of the shares and will vest and become exercisable with respect to an additional 1000 shares on April 2, 2023, and an additional 2000 shares on April 2, 2024, subject to continuous service.
- [F4]In the Form 4 filed for the Reporting Person on April 20, 2022, such Form 4 inadvertently reported in column 9 that 1,250 shares remained subject to this option following exercise as reported in such Form 4. Such Form 4 should have reported in column 9 that 4,250 shares remained subject to this option following exercise. This has been corrected in this Form 4 by reflecting that 3,000 shares remain subject to this option following the Reporting Person's exercise of the employee options for 1,250 shares on November 15, 2022.
- [F5]This stock option award is vested and exercisable with respect to 400 of the shares and will vest and become exercisable with respect to an additional 400 shares on April 29, 2023, an additional 600 shares on April 29, 2024, an additional 600 shares on April 29, 2025, an additional 800 shares on April 29, 2026, and an additional 800 shares on April 29, 2027, subject to continuous service.